How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/biological-dmards.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Biological DMARDs — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biological DMARDs (Biological DMARDs) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biological DMARD. Area: Immunology.

phase 2 Biological DMARD TNF-alpha, IL-6, JAK Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Biological DMARDs (Biological DMARDs) — Hoffmann-La Roche. Biological DMARDs work by targeting specific proteins involved in the immune response to reduce inflammation and slow disease progression.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Biological DMARDs TARGET	Biological DMARDs	Hoffmann-La Roche	phase 2	Biological DMARD	TNF-alpha, IL-6, JAK
non-biological DMARDs	non-biological DMARDs	Hoffmann-La Roche	marketed	Non-biological DMARD (Disease-Modifying Antirheumatic Drug)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biological DMARD class)

Hoffmann-La Roche · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Biological DMARDs — Competitive Intelligence Brief. https://druglandscape.com/ci/biological-dmards. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing